Clinical features of NMO according to brain MRI findings

Brain and Nerve

Volumn 62, Issue 9, 2010, Pages 933-943

  Shimizu, Yuko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Aquaporin 4; MRI brain lesion; Multiple sclerosis; Neuromyelitis opitica (NMO)

Indexed keywords

AQUAPORIN 4; AUTOANTIBODY; BIOLOGICAL MARKER; NMO IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

BRAIN REGION; CLINICAL FEATURE; ENDOCRINE DISEASE; HICCUP; HUMAN; HYPERSOMNIA; MEDULLA OBLONGATA; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NARCOLEPSY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PROTEIN EXPRESSION; REVIEW; ADULT; BRAIN; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA;

EID: 77957678175     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, et al: Brain abnormalities in neuromyelitis optica. Arch Neurol 63: 390-396, 2006
2. Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, et al: Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77: 1073-1075, 2006 (Pubitemid 44338534)
3. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF et al: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112, 2004
4. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR et al: IgG marker of optic-spinal mutiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473-477, 2005
5. Amiry-Moghaddam M, Ottersen OP: The molecular basis of water transport in the brain. Nat Rev Neurosci 4: 991-1001, 2003
6. Frigeri A, Gropper MA, Turck CW, Verkman AS: Immunolocalization of the mercurial intensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc Natl Acad Sci U S A 92: 4328-4331, 1995
7. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG: The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-1114, 1999
8. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, et al: Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63: 964-968, 2006
9. Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y: Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 65: 1479-1482, 2005
10. Takahashi T, Miyazawa I, Misu T, Takano R, Nakashima I, et al: Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin antibody: a herald of acute exacerbation. J Neurol Neyrosurg Psychiatry 79:1075-1078, 2008
11. Nishino S, Kanbayashi T: Symptomatic narcolepsy, catalepsy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 9: 269-310, 2005 (Pubitemid 40982498)
12. Nozaki H, Shimohata T, Kanbayashi T, Sagawa Y, Katada S, et al: A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions. Sleep Med 10: 253-255, 2009
13. Baba T, Nakashima I, Kanbayashi T, Konno M, Takahashi T, et al: Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody. J Neurol 256: 287-288, 2009
14. Kanbayashi T, Shimohata T, Nakashima I, Yaguchi H, Yabe I, et al: Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications. Arch Neurol 66: 1563-1566, 2009
15. Varnant JC, Cabre P, Smadja D, Merle H, Caubarrére I, et al: Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology 48: 58-64, 1997 (Pubitemid 27039518)
16. Poppe AY, Lapierre Y, Melançon D, LowdenD, Wardell L, et al: Neuromyelitis optica with hypothalamic involvement. Mult Scler 11: 617-621, 2005
17. Yamasaki K, Horiuchi I, Minohara M, Osoegawa M, Kawano Y, et al: Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med 39: 296-299,2000
18. Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, de Almeida AM, Oliveira S, et al: Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 73: 429-435, 2002
19. Petravic D, Habek M, Supe S, Brinar VV: Recurrent optic neuromyelitis with endocrinopathies: a new syndrome or just a coincidence? Mult Scler 12: 670-673, 2006
20. Magaña SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, et al: Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 72: 712-717, 2009
21. Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, et al: Hypertensive encephalopahty: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 159: 379-383, 1992
22. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, et al: Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6: 159-163, 2000
23. Papadopoulos MC, Manley GT, Krishna S, Verkman AS: Aqaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 18: 1291-1293, 2004 (Pubitemid 39561580)
24. Matsushita T, Isobe N, MatsuokaT, Ishizu T, Kawano Y, et al: Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions. Mult Scler 15; 1113-1117, 2009
25. Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S: "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 66: 425-428, 2009
26. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, et al: Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130: 1224-1234, 2007 (Pubitemid 47355951)
27. Nakamura M, Misu T, Fujihara K, Miyazawa I, Nakashima I, et al: Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler 15: 695-700, 2009
28. Shimizu Y, Yokoyama K, Misu T, Takahashi T, Fujihara K, et al: Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol 255: 305-307, 2008
29. Krumbholz M, Faber H, Steinmeyer F, Hoffmann LA, Kümpfel T, et al: Interferon-beta increases BAFF levels in multiple sclerosis: implication for B cell antoimmunity. Brain 131: 1455-1463, 2008
30. Matsushita T, Isobe N, Piao H, Matsuoka T, Ishizu T, et al: Peappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status. J Neurol Sci 2010, E-Pub (doi:10.1016/j.jns.2010.01.009)
31. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, et al: Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120: 2059-2069, 1997
32. Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, et al: MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38: 180-185, 1988